Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report
kblankenship
Mon, 10/19/2020 – 08:33